NMPA Approval

Compound Paracetamol and Amantadine Hydrochloride Capsules

Approval Number

国药准字H20094227

Company福建太平洋制药有限公司

Registration Date

May 6, 2024

Drug Information

Generic Name

复方氨酚烷胺胶囊

Brand Name

太平

Dosage Form

胶囊剂

Strength

复方

Drug Type

化学药品

Registration Date

May 6, 2024

Company Information

Applicant Company

Company Name福建太平洋制药有限公司

Company Address

福建省泉州经济技术开发区清濛园区雅泰路1号

Manufacturing Company

Company Name福建太平洋制药有限公司

Company Address

福建省泉州经济技术开发区清濛园区雅泰路1号1~3栋(1~3号楼)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

复方氨酚烷胺胶囊 - NMPA 批准文号 | MedPath